维普中文期刊产品整合服务
58篇 您的检索式:作者名="Gibson RC"
    题名 作者 年代 出处 被引量
1Receptor binding radiotracers: a class of potential radiopharmaceuticals显示文摘Eckelman WC Reba RC Gibson RE 1979J Nucl Med1979,20,4:1
2A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,11:1
3A randomized trial of exemestane after two to three years of tamoxifen therapy in post-menopausal women with primary breast cancer 显示文摘Coombes RC Hall E Gibson IJ 2004N Engl J Med2004,350,11:1
4A randomized trial of exmestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004New Engl J Med2004,350,11:1
5Airway eosinophilia is associated with wheeze but is uncommon in children with persistent cough and frequent chest colds 显示文摘Gibson PG Simpson JL Chalmens AC Toneguzzi RC Wark PA Wilson AJ 2001AmJ Respir Crit Care Med2001,164,6:1
6Traumatic brain injury and the effects of diazepam, dihiazem, and MK-801 on GABA- A receptor subunit expression in rat hippocampus 显示文摘Gibson C J Meyer RC Hamm RJ 2010J Biomed Sci2010,17,:1
7A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer 显示文摘Coombes RC Hall E Gibson LJ etal 2004N EnglJ Med2004,350,11:1
8A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer 显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,11:1
9A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,11:1
10Distributions of the two-dimensional DCT coefficients for images显示文摘REININGER RC GIBSON JD 1983IEEE Transactions Communications1983,31,6:1
11A randomized trial of ex emestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer显示文摘Coombes RC HaU E Gibson LJ 2004N Engl J Med2004,350,11:1
12A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer 显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,11:1
13A randomized trial of exmestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,11:1
14A randomized trial of exmestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer 显示文摘Coombes RC Hall E Gibson LJ 2004New Engl J Med2004,350,11:1
15Arandomized trail of exmes - tanse after two to three years of tamoxifen therapy in post - menopausal women with primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,11:1
16Application of sensitive and specific molecular methods to uncover global dissemination of the major RDRio sublineage of the Latin American Mediterranean Mycobacte- rium tuberculosis spoligotype family 显示文摘Gibson AL Huard RC Gey van Pittius NC Lazzarini LC Driscoll J 2008Clin Microbiol2008,46,:1
17Antiplatelet therapy in acute coronary syndrome(ACS):applying new science to clinical decisions显示文摘Becker RC Gibson CM Jennings LK 2010Am J Cardiol2010,106,8:1
18A randomized trial of ex- emestane after two to three years of tamoxifen therapy in postm- enopausal women with primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,6:1
19Intergroup Exemestane Study:A randomised trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,:1
20A randomized rial of exemestaneafter two to three years of tamoxifen therapy in postmenopausal womenwith primary breast cancer显示文摘Coombes RC Hall E Gibson LJ 2004N Engl J Med2004,350,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费